Neurobiology of Aging
Volume 27, Issue 10 , Pages 1372-1384 , October 2006

Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment

  • Stephen W. Scheff

      Affiliations

    • Sanders-Brown Center on Aging and the Alzheimer's Disease Research Center, University of Kentucky College of Medicine, 101 Sanders-Brown, Lexington, KY 40536-0230, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 859 257 1412x270; fax: +1 859 323 2866.
    • ,
  • Douglas A. Price

      Affiliations

    • Sanders-Brown Center on Aging and the Alzheimer's Disease Research Center, University of Kentucky College of Medicine, 101 Sanders-Brown, Lexington, KY 40536-0230, USA
    • ,
  • Frederick A. Schmitt

      Affiliations

    • Sanders-Brown Center on Aging and the Alzheimer's Disease Research Center, University of Kentucky College of Medicine, 101 Sanders-Brown, Lexington, KY 40536-0230, USA
    • ,
  • Elliott J. Mufson

      Affiliations

    • Department of Neurological Sciences and Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA

Received 24 May 2005 ,Revised 2 September 2005 ,Accepted 9 September 2005.

References 

  1. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology. 1992;42:1681–1688
  2. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurses’ ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology. 1997;49:1580–1587
  3. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198–205
  4. Bertoni-Freddari C, Fattoretti P, Casoli T, Meier-Ruge W, Ulrich J. Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer's disease. Brain Res. 1990;517:69–75
  5. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–259
  6. Braak H, Braak E. Pathology of Alzheimer's disease. In:  Calne D editors. Neurodegenerative diseases. Philadelphia: Saunders; 1994;p. 585–613
  7. Brown DF, Risser RC, Bigio EH, Tripp P, Stiegler A, Welch E, et al. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J Neuropathol Exp Neurol. 1998;57:955–960
  8. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, et al. Expression of human apolipoprotein E3 or E4 in the brains of Apoe−/− mice: isoform-specific effects on neurodegeneration. J Neurosci. 1999;19:4867–4880
  9. Cabalka LM, Hyman BT, Goodlett CR, Ritchie TC, Van Hoesen GW. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions. Neurobiol Aging. 1992;13:283–291
  10. Caceres A, Steward O. Dendritic reorganization in the denervated dentate gyrus of the rat following entorhinal cortex lesions. A Golgi and electron microscopic analysis. J Comp Neurol. 1983;214:387–403
  11. Calverley RKS, Jones DG. Determination of numerical density of perforated and nonperforated synapses. In:  Conn PM editors. Quantitative and qualitative microscopy. vol. 3:New York: Academic Press; 1990;p. 155–172
  12. Carlesimo GA, Sabbadini M, Fadda L, Caltagirone C. Word-list forgetting in young and elderly subjects: evidence for age-related decline in transferring information from transitory to permanent memory condition. Cortex. 1997;33:155–166
  13. Chetelat G, Baron JC. Early diagnosis of Alzheimer's disease: contribution of structural neuroimaging. Neuroimage. 2003;18:525–541
  14. Convit A, De Leon MJ, Tarshish C, De Santi S, Tsui W, Rusinek H, et al. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol Aging. 1997;18:131–138
  15. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921–923
  16. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, et al. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology. 1988;38:1682–1687
  17. Davies CA, Mann DMA , Sumpter PW, Yates PO. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci. 1987;78:151–164
  18. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol. 1999;58:376–388
  19. Dayan AD. Quantitative histological studies on the aged human brain. I. Senile plaques and neurofibrillary tangles in “normal” patients. Acta Neuropathol (Berl). 1970;16:85–94
  20. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging. 2001;22:529–539
  21. DeKosky ST, Ikonomovic MD, Styren SD, Beckett L, Wisniewski S, Bennett DA, et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol. 2002;51:145–155
  22. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol. 1990;27:457–464
  23. deToledo-Morrell L, Stoub TR, Bulgakova M, Wilson RS, Bennett DA, Leurgans S, et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging. 2004;25:1197–1203
  24. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging. 2001;22:747–754
  25. Du AT, Schuff N, Amend D, Laakso MP, Hsu YY, Jagust WJ, et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001;71:441–447
  26. Duvernoy HM. The human hippocampus. Paris: Springer; 1998;
  27. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA. 1997;278:1349–1356
  28. Fellgiebel A, Wille P, Muller MJ, Winterer G, Scheurich A, Vucurevic G, et al. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord. 2004;18:101–108
  29. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41:1006–1009
  30. Ganeshina O, Berry RW, Petralia RS, Nicholson DA, Geinisman Y. Differences in the expression of AMPA and NMDA receptors between axospinous perforated and nonperforated synapses are related to the configuration and size of postsynaptic densities. J Comp Neurol. 2004;468:86–95
  31. Ganeshina O, Berry RW, Petralia RS, Nicholson DA, Geinisman Y. Synapses with a segmented, completely partitioned postsynaptic density express more AMPA receptors than other axospinous synaptic junctions. Neuroscience. 2004;125:615–623
  32. Geddes J, Anderson K, Cotman C. Senile plaques as aberrant sprout-stimulating structures. Exp Neurol. 1986;94:767–776
  33. Geddes J, Monahan D, Cotman C, Lott IT, Kim R, Chui H. Plasticity of hippocampal circuitry in Alzheimer's disease. Science. 1985;230:1179–1181
  34. Geddes JW, Cotman CW. Plasticity, pathology, and Alzheimer's disease. Neurobiol Aging. 1989;10:571–573discussion 88–90
  35. Geddes JW, Cotman CW. Plasticity in Alzheimer's disease: too much or not enough?. Neurobiol Aging. 1991;12:330–333
  36. Goldman WP, Price JL, Storandt M, Grant EA, McKeel DW, Rubin EH, et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology. 2001;56:361–367
  37. Goldstein LB, Samsa GP. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke. 1997;28:307–310
  38. Gomez-Isla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996;16:4491–4500
  39. Goto S, Hirano A. Neuronal inputs to hippocampal formation in Alzheimer's disease and in parkinsonism–dementia complex on Guam. Acta Neuropathol. 1990;79:545–550
  40. Guillozet AL, Weintraub S, Mash DC, Mesulam MM. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol. 2003;60:729–736
  41. Gundersen HJG . Stereology of arbitrary particles. J Microsc. 1986;143:3–45
  42. Gundersen HJG, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1988;96:857–881
  43. Gundersen HJG , Osterby R. Optimizing sampling effciency of stereological studies in bioogy: or ‘Do more less well!’. J Microsc. 1981;65–73
  44. Hamos J, DeGennaro L, Drachman D. Synaptic loss in Alzheimer's disease and other dementias. Neurology. 1989;39:355–361
  45. Hayat MA. Electron microscopy: biological applications. 4th ed.. Cambridge: Cambridge University Press; 2000;
  46. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–1122
  47. Hirano A, Zimmerman HM. Alzheimer's neurofibrillary changes. Arch Neurol. 1962;37:227–242
  48. Hoff SF, Scheff SW, Benardo LS, Cotman CW. Lesion-induced synaptogenesis in the dentate gyrus of aged rats. I. Loss and reacquisition of normal synaptic density. J Comp Neurol. 1982;205:246–252
  49. Huang Y, Weisgraber KH, Mucke L, Mahley RW, Apolipoprotein E. diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J Mol Neurosci. 2004;23:189–204
  50. Hubbard BM, Fenton GW, Anderson JM. A quantitative histological study of early clinical and preclinical Alzheimer's disease. Neuropathol Appl Neurobiol. 1990;16:111–121
  51. Hyman B, Van Hoesen G, Kromer L, Damasio A. Perforant pathway changes and memory impairment of Alzheimer's disease. Ann Neurol. 1986;20:472–481
  52. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol. 1997;56:1095–1097
  53. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 1984;225:1168–1170
  54. Ihara Y. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease. Brain Res. 1988;459:138–144
  55. Insausti R, Amaral DG. Hippocampal formation. In:  Paxionos G,  Mai JK editor. The human nervous system. San Diego: Elsevier Academic Press; 2004;p. 871–914
  56. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988;23:138–144
  57. Kazee AM, Johnson EM. Alzheimer's disease pathology in non-demented elderly. J Alzheimer Dis. 1998;1:81–89
  58. Killiany RJ, Hyman BT, Gomez-Isla T, Moss MB, Kikinis R, Jolesz F, et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 2002;58:1188–1196
  59. Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D, et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol. 2001;49:202–213
  60. Lippa CF, Hamos JE, Pulaski-Salo D, Degennaro LJ, Drachman DA. Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging. 1992;13:405–411
  61. Lipton AM, Cullum CM, Satumtira S, Sontag E, Hynan LS, White CL, et al. Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. Arch Neurol. 2001;58:1233–1239
  62. Masliah E, Ellisman M, Carragher B, Mallory M, Young S, Hansen L, et al. Three dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease. J Neuropathol Exp Neurol. 1992;51:404–414
  63. Masliah E, Mallory M, Alford M, DeTeresa R, Hansen LA, McKeel DW, et al. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology. 2001;56:127–129
  64. Masliah E, Terry R, DeTeresa R, Hansen L. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci Lett. 1989;103:234–239
  65. Masliah E, Terry RD, Alford M, DeTeresa R, Hansen LA. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease. Am J Pathol. 1991;138:235–246
  66. McKeel DW, Ball MJ, Price JL, Smith DS, Miller JP, Berg L, et al. Interlaboratory histopathologic assessment of Alzheimer neuropathology: different methodologies yeild comparable diagnostic results. Alzheimer Dis Assoc Disord. 1993;7:136–151
  67. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  68. Medina D, deToledo-Morrell L, Urresta F, Gabrieli JDE, Moseley M, Fleischman D, et al., White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol Aging 2005, in press.
  69. Mesulam M, Shaw P, Mash D, Weintraub S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol. 2004;55:815–828
  70. Michel RP, Cruz-Orive LM. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J Microsc. 1988;150:117–136
  71. Morris JC, McKeel DW, Storandt M, Rubin EH, Price JL, Grant EA, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology. 1991;41:469–478
  72. Morris JC, Storandt M, McKeel SW, Rubin EH, Price JL, Grant EA, et al. Cerebral amyloid deposition and diffuse plaques in “normal” aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 1996;46:707–719
  73. Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999;158:469–490
  74. Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 2000;427:19–30
  75. Nicholson DA, Yoshida R, Berry RW, Gallagher M, Geinisman Y. Reduction in size of perforated postsynaptic densities in hippocampal axospinous synapses and age-related spatial learning impairments. J Neurosci. 2004;24:7648–7653
  76. Pakkenberg B, Gundersen JG. Neocortical neuron number in humans: effect of sex and age. J Comp Neurol. 1997;384:312–320
  77. Parkin AJ, Lawrence A. A dissociation in the relation between memory tasks and frontal lobe tests in the normal elderly. Neuropsychologia. 1994;32:1523–1532
  78. Paula-Barbosa MM, Saraiva A, Tavares MA, Borges MM, Verwer RWH. Alzheimer's disease: maintenance of neuronal and synaptic densities in frontal cortical layers II and III. Acta Neurol Scand. 1986;74:404–408
  79. Perdahl E, Adolfsson R, Alafuzoff I, Albert KA, Nestler EJ, Greengard P, et al. Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia. J Neural Trans. 1984;60:133–141
  80. Peters A, Palay SL, Webster H. The fine structure of the nervous system. New York: Oxford University Press; 1991;
  81. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308
  82. Pittman J, Andrews H, Tatemichi T, Link B, Struening E, Stern Y, et al. Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis. Arch Neurol. 1992;49:461–467
  83. Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease. Ann Neurol. 1999;45:358–368
  84. Price LJ, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in health aging and Alzheimer's disease. Neurobiol Aging. 1991;12:295–312
  85. Probst A, Basler V, Bron B, Ulrich J. Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res. 1983;268:249–254
  86. Reynolds ES. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol. 1963;17:208
  87. Rubin EH, Morris JC, Grant EA, Vendegna T. Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol. 1989;46:379–382
  88. Sabo T, Lomnitski L, Nyska A, Beni S, Maronpot RR, Shohami E, et al. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience. 2000;101:879–884
  89. Samuel W, Masliah E, Hill LR, Butters N, Terry R. Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology. 1994;44:2081–2088
  90. Scheff SW. Synaptic reorganization after injury: the hippocampus as a model system. In:  Seil FJ editors. Neural regeneration and transplantation. New York: Alan R. Liss; 1989;p. 137–156
  91. Scheff SW, DeKosky ST, Price DA. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol Aging. 1990;11:29–37
  92. Scheff SW, Price D. Synapse loss in the temporal lobe in Alzheimer's disease. Ann Neurol. 1993;33:190–199
  93. Scheff SW, Price DA. Synaptic density in the inner molecular layer of the hippocampal dentate gyrus in Alzheimer disease. J Neuropathol Exp Neurol. 1998;57:1146–1153
  94. Scheff SW, Price DA. Alzheimer's disease-related synapse loss in the cingulate cortex. J Alzheimer Dis. 2001;3:495–505
  95. Scheff SW, Price DA. Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol Aging. 2003;24:1029–1046
  96. Scheff SW, Sparks DL, Price DA. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia. 1996;7:213–220
  97. Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. “Preclinical” AD revisited: neuropathology of cognitively normal older adults. Neurology. 2000;55:370–376
  98. Sheng H, Laskowitz DT, Bennett E, Schmechel DE, Bart RD, Saunders AM, et al. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab. 1998;18:361–366
  99. Squire LR, Zola-Morgan S. Memory: brain systems and behavior. Trends Neurosci. 1988;11:170–175
  100. Sterio DC. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc. 1984;134:127–136
  101. Steward O, Vinsant SL, Davis L. The process of reinnervation in the dentate gyrus of adult rats: an ultrastructural study of changes in presynaptic terminals as a result of sprouting. J Comp Neurol. 1988;267:203–210
  102. Stoub TR, Bulgakova M, Leurgans S, Bennett D, Fleischman D, Turner DA, et al. MRI-predictors of risk incident Alzheimer's disease: a longitudinal study. Neurology. 2005;64:1520–1524
  103. Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol. 1997;56:933–944
  104. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572–580
  105. Tigges J, Herndon JG, Rosene DL. Preservation into old age of synaptic number and size in the supragranular layer of the dentate gyrus in rhesus monkeys. Acta Anat (Basel). 1996;157:63–72
  106. Uylings HB, van Eden CG, Hofman MA. Morphometry of size/volume variables and comparison of their bivariate relations in the nervous system under different conditions. J Neurosci Methods. 1986;18:19–37
  107. Van Hoesen GW, Hyman BT, Damasio AR. Entorhinal cortex pathology in Alzheimer's disease. Hippocampus. 1991;1:1–8
  108. Visser PJ, Scheltens P, Verhey FR, Schmand B, Launer LJ, Jolles J, et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol. 1999;246:477–485
  109. Visser PJ, Verhey FR, Hofman PA, Scheltens P, Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry. 2002;72:491–497
  110. Weibel E. Point counting method. In:  Weibel ER editors. Stereological method. vol. 1:London: Academic Press; 1979;p. 101–161
  111. West MJ, Gundersen HJG. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol. 1990;296:1–22
  112. West MJ, Slomianka L, Gundersen HJG. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical frationator. Anat Rec. 1991;231:482–497
  113. Witter MP, Amaral DG. Entorhinal cortex of the monkey. V. Projections to the dentate gyrus, hippocampus, and subicular complex. J Comp Neurol. 1991;307:437–459
  114. Wolf H, Grunwald M, Kruggel F, Riedel-Heller SG, Angerhofer S, Hojjatoleslami A, et al. Hippocampal volume discriminates between normal cognition; questionable and mild dementia in the elderly. Neurobiol Aging. 2001;22:177–186
  115. Wolf H, Hensel A, Kruggel F, Riedel-Heller SG, Arendt T, Wahlund LO, et al. Structural correlates of mild cognitive impairment. Neurobiol Aging. 2004;25:913–924
  116. Wolf H, Jelic V, Gertz HJ, Nordberg A, Julin P, Wahlund LO. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand Suppl. 2003;179:52–76
  117. Xu Y, Jack CR, O’Brien PC, Kokmen E, Smith GE, Ivnik RJ, et al. Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD. Neurology. 2000;54:1760–1767
  118. Zhan S-S, Beyreuther K, Schmitt HP. Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia. Dementia. 1993;4:66–74

PII: S0197-4580(05)00283-6

doi: 10.1016/j.neurobiolaging.2005.09.012

Neurobiology of Aging
Volume 27, Issue 10 , Pages 1372-1384 , October 2006

Article Tools

* Image Usage & Resolution